Expanded Portfolio Centerpiece of GlobalSubmit’s DIA eRI 2015 Exhibit Presentation
GlobalSubmit Inc., (www.globalsubmit.com) an industry leader in technology solutions and professional services to support regulated product submissions, will exhibit its complete portfolio, including early prototype versions of Regulatory Information (RIMS) and Document Management Systems (DMS) at the 2015 DIA eRegulatory and Intelligence Annual Conference.
The conference is being held May 11-13 at the Sheraton Downtown Hotel located in Center City Philadelphia just blocks from GlobalSubmit company headquarters.
“Much like DIA’s leadership has broadened the scope of this conference to encompass all subsets of regulatory information management, we’ve expanded our offerings to serve the entire regulatory market,” said GlobalSubmit CEO Rahul Mistry. “Information destined for regulatory submission travels along a path and all points along that path are related and full of inefficiencies to exploit.”
“When Philadelphia last hosted a major DIA conference in 2012, GlobalSubmit’s flagship products were REVIEW and VALIDATE while our PUBLISH product was growing in popularity,” Mistry added.” Today, our PUBLISH software is an innovative, mature solution that is the second most used publishing solution in the marketplace. We also have a world-class services department and are introducing new products for end-to-end management of regulatory information. GlobalSubmit now provides a complete solution for our clients’ needs.”
GlobalSubmit will be presenting at Booth #102 in the main exhibit hall. Demonstrations of our prototype RIMS and DMS product are available by appointment during the conference.
On the second day of the conference GlobalSubmit’s eSubmission Suite Product Manager Robert Connelly will present “Preparing for the New Module 1 (3.3 Format)” alongside representatives of the FDA and clients who have participated in the FDA’s M1 pilot program. The latest release of GlobalSubmit’s publishing software is in full compliance with the new Module 1 specifications the FDA is scheduled to implement later this year. Mr. Connelly’s presentation is scheduled for Tuesday, May 12 at 8:30 a.m.—10:00 a.m.